Health Care & Life Sciences » Biotechnology | Hamilton Thorne Ltd.

Hamilton Thorne Ltd. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
478.10
1,825.70
5,963.90
2,464.40
7,196.20
18,670.30
Total Accounts Receivable
666.60
1,118.70
1,680.00
2,197.50
3,424.60
4,251.70
Inventories
745.90
742.10
910.90
1,511.90
3,035.70
4,512.60
Other Current Assets
97.70
134.60
194.50
156.60
513.90
471.40
Total Current Assets
1,988.20
3,821.20
8,749.30
6,330.40
14,170.40
27,906
Net Property, Plant & Equipment
83.30
62.60
70.20
385.50
826.50
885.40
Intangible Assets
81.30
211.80
950.40
9,546.70
26,838.20
28,708.60
Other Assets
78.40
85.50
102.50
155.70
145.50
158.60
Total Assets
2,231.20
4,181.10
9,872.40
16,418.30
48,042.70
65,850.40
ST Debt & Current Portion LT Debt
89.40
87.80
499.20
1,738.60
2,201.90
Accounts Payable
1,600.00
1,721.60
1,891.30
1,904.40
3,044.20
Income Tax Payable
-
-
-
-
134.20
Other Current Liabilities
44.40
42.10
66.60
115.40
2,922.20
Total Current Liabilities
1,733.90
1,851.40
2,457.10
3,758.40
8,302.40
Long-Term Debt
4,036.20
4,388.00
4,861.90
7,884.00
11,643.60
Deferred Taxes
-
-
-
-
5,256.10
Other Liabilities
16.60
9.30
284.50
211.80
128.10
Total Liabilities
5,786.70
6,248.70
7,603.40
11,854.30
20,880.10
Common Equity (Total)
3,555.40
2,067.70
2,269.00
4,564.00
27,162.60
Total Shareholders' Equity
3,555.40
2,067.70
2,269.00
4,564.00
27,162.60
Total Equity
3,555.40
2,067.70
2,269.00
4,564.00
27,162.60
Liabilities & Shareholders' Equity
2,231.20
4,181.10
9,872.40
16,418.30
48,042.70

About Hamilton Thorne

View Profile
Address
100 Cummings Center
Beverly Massachusetts 01915
United States
Employees -
Website http://www.hamiltonthorne.ltd
Updated 07/08/2019
Hamilton Thorne Ltd. engages in design, manufacture and distribution of laser devices and image analysis systems for the fertility, stem cell, and development biology research markets. It sells its products through direct sales and distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments. The company was founded by Meg Spencer and Diarmaid H.